Research on B-cell chronic lymphocytic leukemia (CLL), the most frequent leukemia in western world

Copyright Lennart Nilsson, Cellmaterial Anders Rosén Foto: Copyright Lennart Nilsson, cell material Anders Rosén

We are investigating novel signalling pathways and the influence of redox-regulation in chronic lymphocytic leukemia (CLL). 

Our research team is exploring the phenomena of anergy (immunological unresponsiveness) upon exposure of microbial and self-antigens, as well as synergy (microenvironmental support) in the leukemogenesis of CLL.

PublicationsShow/Hide content

2020

My reseach in media

Science Magazine: "White blood cells launch DNA ‘webs’ to warn of invaders" (2018-01-03)
 

Publications in ORCHIDShow/Hide content

Please see my publications in ORCHID

 

ResearchShow/Hide content

About meShow/Hide content

Collaboration 

We collaborate with several groups including:

  • Prof Richard Rosenquist, Uppsala
  • Prof Kostas Stamatopoulos, Greece
  • Prof Sohvi Hörkkö, Finland
  • Prof Giannis Spyrou, LiU
  • Prof Mårten Segelmark, LiU
  • Prof Mikael Lindgren, LiU
  • Ass. Prof. Anette Gjörloff

Networks

  • Board member of Swedish CLL group
  • Reviewer for Swedish Cancer Society
  • PhD thesis evaluation committees
  • PhD thesis opponent
  • Reviewer for International Hematology Journals 
  • PhD tutor

More

Teaching program: PhD scientific literature courses – journal club

Discovery of the year 2009, awarded by the Swedish Cancer Association

Social media

Related ResearchShow/Hide content

Cell and Molecular Biology

Molecular Biology research focus on  how molecules and systems within cells interact. Of special interest is the flow of genetic information from DNA via RNA to protein synthesis, and how these processes are regulated.

Cancerceller, illustration

Cancer and Hematology

Cancer is a unifying concept for a number of diseases where abnormal cells divide , sometimes uncontrolled and invading other tissues.

Wallenberg Centre for Molecular Medicine at LiU

WCMM at LiU focuses on the medicine-technology interface, and build upon our existing strengths in research within medical technology, materials science and bioengineering.

OrganisationShow/Hide content

Tags Show/Hide content